What is the address of DOCPHARMA?

The registered office of DOCPHARMA is located at Terhulpsesteenweg 6 box A, 1560 Hoeilaart.

Is DOCPHARMA still active?

Yes. According to the CBE (29 October 2026) DOCPHARMA is active, legal situation “Normale toestand”, started on 5 March 1999.

Is DOCPHARMA registered on Peppol?

Yes, DOCPHARMA is registered on the Peppol network with ID 0208:0465350075.

What is the enterprise number of DOCPHARMA?

The enterprise number of DOCPHARMA is BE0465350075.

When was DOCPHARMA founded?

DOCPHARMA was founded on 5 March 1999.

Who are the directors of DOCPHARMA?

According to the 2025 annual accounts, the directors of DOCPHARMA are: Arun NARAYAN, Tomasz BUCZEK.

Is DOCPHARMA a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 5 March 1999; 4 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did DOCPHARMA make in 2025?

DOCPHARMA posted a profit after taxes of € 581,444 in financial year 2025.

DOCPHARMA (Private Limited) - Hoeilaart - BE0465350075

Dossier DOCPHARMA, printed on 29 October 2026 from databakkes.be/en/0465350075/docpharma. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DOCPHARMA from Hoeilaart, company number BE0465350075, closed financial year 2025 with a result of € 581,444 after tax. Compared with financial year 2024, the result moved from € 1.2 million to € 581,444. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 7, 2026.

What it is worth Growing

€ 36.6 million

▲ 2% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 581,444

▼ 52% vs 2024

Profit after tax over the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € -46.7 million.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 13,685

▲ 10% vs 2024

Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 200 days on average.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Profit after taxes	€ 1,235,917 Profit after taxes 2022: € 1,235,917 First fiscal year in the series	€ 788,648 Profit after taxes 2023: € 788,648 ▼ 36% vs 2022 (€ 1,235,917) Unfavourable step	€ 1,206,286 Profit after taxes 2024: € 1,206,286 ▲ 53% vs 2023 (€ 788,648) Favourable step	€ 581,444 Profit after taxes 2025: € 581,444 ▼ 52% vs 2024 (€ 1,206,286) Unfavourable step	▼ 52%
Equity	€ 33,974,802 Equity 2022: € 33,974,802 First fiscal year in the series	€ 34,763,450 Equity 2023: € 34,763,450 ▲ 2% vs 2022 (€ 33,974,802) Favourable step	€ 35,969,736 Equity 2024: € 35,969,736 ▲ 3% vs 2023 (€ 34,763,450) Favourable step	€ 36,551,180 Equity 2025: € 36,551,180 ▲ 2% vs 2024 (€ 35,969,736) Favourable step	▲ 2%
Total debts	€ 14,466 Total debts 2022: € 14,466 First fiscal year in the series	€ 27,707 Total debts 2023: € 27,707 ▲ 92% vs 2022 (€ 14,466) Unfavourable step	€ 12,465 Total debts 2024: € 12,465 ▼ 55% vs 2023 (€ 27,707) Favourable step	€ 13,685 Total debts 2025: € 13,685 ▲ 10% vs 2024 (€ 12,465) Unfavourable step	▲ 10%
Cash	€ 49,432 Cash 2022: € 49,432 First fiscal year in the series	€ 0 Cash 2023: € 0 ▼ 100% vs 2022 (€ 49,432) Unfavourable step	-	-
Retained profit	€ -49,315,571 Retained profit 2022: € -49,315,571 First fiscal year in the series	€ -48,526,924 Retained profit 2023: € -48,526,924 ▲ € 788,648 vs 2022 (€ -49,315,571) Favourable step	€ -47,320,637 Retained profit 2024: € -47,320,637 ▲ € 1.2 million vs 2023 (€ -48,526,924) Favourable step	€ -46,739,193 Retained profit 2025: € -46,739,193 ▲ € 581,444 vs 2024 (€ -47,320,637) Favourable step	▲ € 581,444
Balance sheet total	€ 44,271,677 Balance sheet total 2022: € 44,271,677 First fiscal year in the series	€ 45,525,196 Balance sheet total 2023: € 45,525,196 ▲ 3% vs 2022 (€ 44,271,677) Unchanged	€ 47,169,110 Balance sheet total 2024: € 47,169,110 ▲ 4% vs 2023 (€ 45,525,196) Unchanged	€ 48,203,405 Balance sheet total 2025: € 48,203,405 ▲ 2% vs 2024 (€ 47,169,110) Unchanged	▲ 2%

Key figures of DOCPHARMA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DOCPHARMA?

What happened at DOCPHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 7, 2026 New annual accounts for financial year 2025: profit of € 581,444 (▼ 52% vs 2024). Source: NBB ↗
2025 Arun NARAYAN became a director. NBB
2025 Tomasz BUCZEK became a director. NBB
Nov 23, 1999 New establishment in Hoeilaart. KBO
Mar 5, 1999 Start of the company according to the CBE. KBO

In short

From € 1.2 million profit in 2022 to € 581,444 profit in 2025.

Paid € 33,889 in corporate taxes since 2022.

Best year ever: 2022, with € 1.2 million profit.

Pays suppliers within 200 days on average.

Original PDFs at the National Bank ↗

Management

Viatris BV 100%

DOCPHARMA

AKTUAPHARMA BV 100%

Behind DOCPHARMA are Arun NARAYAN and Tomasz BUCZEK. The shares are held by Viatris BV (100%). It owns 100% of AKTUAPHARMA BV itself.

Directors

According to the 2025 annual accounts

Arun NARAYAN

Director

Also active at: Viatris Healthcare, AKTUAPHARMA, Viatris, Viatris GX

since 2025

Tomasz BUCZEK

Director

Also active at: AKTUAPHARMA

since 2025

Shareholders

Viatris BV

100%

Participations

AKTUAPHARMA BV

100%

Establishments

Establishment units

Physical locations of this company

Registered office

Terhulpsesteenweg 6 box A

1560 Hoeilaart

2.103.154.988

Terhulpsesteenweg 6A

1560 Hoeilaart

Active since 23 November 1999

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.

All companies at this address →

Viatris same network

€ 163.7 million revenue · 2025

Matrix Laboratories

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0465.350.075
VAT number: BE 0465.350.075
Registered office: Terhulpsesteenweg 6 bus A, 1560 Hoeilaart
Names & denominations: DOCPHARMA
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 5 March 1999
Peppol: Active · Active since 20 Nov 2020

View on CBE Public ↗ Annual accounts (NBB) ↗